ghk- cu peptide GHK-CU – Research GHK-Cu Peptides Before and After:

The combined action may provide models for evaluating multiple entry points into growth hormone regulation

For patients with significant portal hypertension or ascites, deltoid or lateral thigh injection sites avoid the potentially altered abdominal vascular dynamics

By 72 days, the BPC-157 group showed consistent improvements across essentially every healing parameter: mechanical strength, functional recovery, macroscopic appearance, and microscopic tissue architecture

It is currently in clinical trials for the treatment of inflammatory bowel disease

Researchers could not identify either a minimum toxic dose or a lethal dose despite testing across a three-thousand-fold range of exposures